Skip to search formSkip to main contentSkip to account menu

benfluorex

Known as: Benfluorexum, 1-(3-trifluoromethylphenyl)-2-[N-(2-benzoyloxyethyl)amino]propane, benfluramate 
An antilipidemic agent that decreases the relative rate of hepatic triacylglycerol synthesis. Benfluorex was never approved for use in the United… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Websites and discussion lists on health issues are among the most popular resources on the Web. Use experience reported on social… 
Review
2013
Review
2013
2010
2010
Department of Cardiology, University Hospital Brest, Brest, France; Department of Cardiology, University Hospital Amiens, Amiens… 
2003
2003
Abstract. Six-month efficacy of benfluorex (Mediator) (150–450 mg/day) was assessed in a double-blind multicenter study vs… 
2002
2002
The effects of benfluorex and two of its metabolites (S 422-1 and S 1475-1) on fatty acid and glucose metabolic fluxes and… 
Highly Cited
1995
Highly Cited
1995
To determine whether a reduction in insulinemia would be associated with a rise in serum dehydroepiandrosterone (DHEA) sulfate in… 
1993
1993
OBJECTIVE To evaluate the change in lipids and insulin sensitivity in 10 obese type II diabetic patients after treatment with… 
1977
1977
Rats were treated for 5 days with benfluorex [1-(3-trifluoromethylphenyl)-2-[N-(2-benzoyloxyethyl)amino]propane] or with… 
Highly Cited
1975
Highly Cited
1975
The effects on glycerolipid synthesis of a series of compounds including many drugs were investigated in cell-free preparations…